Chemoselective modification of chitosan with arginine and hydroxyproline: Development of antibacterial composite films for wound healing applications.

This study explored the enhancement of chitosan for wound dressing applications through selective functionalization with arginine and hydroxyproline amino acids, combined with polyvinyl pyrrolidone (PVP) and polyvinyl alcohol (PVA) in composite films. The research employed chemoselective amino acid grafting followed by solution casting to fabricate the composite materials. Fourier transform infrared (FTIR) analysis verified successful chitosan modification through the presence of a carbamate bond at 1719 cm and an amide bond shift from 1660 to 1680 cm, with nuclear magnetic resonance (NMR) analysis providing additional confirmation.

Modification of chitosan using amino acids for wound healing purposes: A review.

Chitosan, a well-known biopolymer due to its unique properties, has received considerable attention as a result of the amine group activity that locates on the backbone of chitosan. To improve the mechanical and antibacterial characteristics of chitosan, various modifications have been used. Amino acids, the monomeric units of proteins, among all other compounds have been chosen to discuss as promising materials for wound healing in combination with chitosan.

Preparation of chitosan-based composites with urethane cross linkage and evaluation of their properties for using as wound healing dressing.

In this research, biocomposite films containing chitosan (CS), polyvinyl alcohol (PVA) and polyvinyl pyrrolidone (PVP), with different ratios, have been provided. The effects of adding hexamethylene 1, 6-di(aminocarboxysulfonate) (HMDACS) as cross-linking agent and the formation of urethane linkage on mechanical properties such as tensile strength, elongation and dynamic-mechanical properties such as storage modulus and tan δ were studied. Also, the antibacterial properties of the composites were investigated by viable bacterial cell counting and compared in reducing the bacterial growth.

Preparation and characterization of acetylated starch nanoparticles as drug carrier: Ciprofloxacin as a model.

The objective of this study was to characterize in-vitro the potential of acetylated corn starch (ACS) particles as a matrix for the delivery of ciprofloxacin (CFx). ACS was successfully synthesized and optimized by the reaction of native corn starch using acetic anhydride and acetic acid with low and high degrees of substitution (DS). The nanoprecipitation method was applied for the formation of the ACS-based nanoparticles, by the dropwise addition of water to acetone solution of ACS under stirring.